Begin main content

Search

We found 62 result(s)

New at CADTH — May 2018

Published on: May 14, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Ocrelizumab (Ocrevus): Primary progressive multiple sclerosis Nitisinone (MDK-Nitisinone): Hereditary tyrosinemia type I Latanoprost (Monoprost): Glaucoma and ocular hypertension CADTH pan-Canadian Oncology Drug Review (pCODR) Alectinib (Alecensaro): Locally advanced or metastatic non‒s...

New at CADTH — April 2018

Published on: April 23, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review (CDR) Tocilizumab (Actemra): Giant cell arteritis (GCA) Tenofovir alafenamide (Vemlidy): Hepatitis B, chronic CDR Update 135: Application Fees for CADTH Pharmaceutical Reviews — Adjustment CADTH pan-Canadian Oncology Drug Review (pCODR) Pembrolizumab (Keytruda): Metastatic Urothelial Ca...

New at CADTH — March 2018

Published on: March 16, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Nitisinone (Orfadin): Hereditary tyrosinemia type 1 Guselkumab (Tremfya): Psoriasis, moderate-to-severe plaque Infliximab (Renflexis): rheumatoid arthritis, ankylosing spondylitis, adult Crohn’s disease, pediatric Crohn’s disease, fistulising Crohn’s disease, adult ulcerative colitis, p...

New at CADTH — February 2018

Published on: February 16, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Migalastat (Galafold): Fabry Disease Cysteamine bitartrate (Procysbi): Nephropathic cystinosis Glecaprevir pibrentasvir (Maviret): Chronic Hepatitis C Apomorphine hydrochloride (Movapo): Parkinson's disease Sofosbuvir velpatasvir voxilaprevir (Vosevi): Chronic Hepatitis C CADTH pan-Cana...

New at CADTH — January 2018

Published on: January 11, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Read the following CDR Update to find out what’s happening in CDR: Issue 132 — Update on Revised Process for Biosimilars, and Clarification Regarding Eligibility Assessments for Resubmissions. Nusinersen (Spinraza): Spinal Muscular Atrophy CADTH pan-Canadian Oncology Drug Review (pCODR)...

New at CADTH — December 2017

Published on: December 11, 2017
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Read the following CDR Update to find out what’s happening in CDR: Issue 130 — Revised Procedure for the CADTH Common Drug Review Resubmissions, Industry Fees are Applicable to all CDR Resubmissions, and Revised Table of Studies Template. Issue 131 — Collaborative Workspaces: Revised Pr...

New at CADTH — November 2017

Published on: November 7, 2017
Result type: Reports
Product Line: New at CADTH

NEWS & EVENTS Evidence-to-Action Series
We are pleased to present, as part of our Evidence-to-Action Series, Home-Based Dialysis in Canada: From Evidence to Practice, on Thursday, November 9, 2017, from 2:00 p.m. to 3:30 p.m. EST, in Ottawa. We are delighted to host Renal Patient Advocate Kirk Kelly, who will provide a patient perspect...

New at CADTH — October 2017

Published on: October 6, 2017
Result type: Reports
Product Line: New at CADTH

NEWS & EVENTS CADTH Lecture Series
On October 12, 2017, Dr. Hakique Virani will be speaking about “Canada’s Opioid Crisis: The Changing Reality Between Exam Rooms and Ivory Towers.” Dr. Virani is currently the Medical Director of Metro City Medical Clinic, and Assistant Clinical Professor in the Department of Medicine at the University...

New at CADTH — September 2017

Published on: September 19, 2017
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Eliglustat (Cerdelga): Gaucher disease AbobotulinumtoxinA (Dysport Therapeutic): Cervical dystonia Etanercept (Erelzi): Ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, rheumatoid arthritis      Glatiramer acetate (Glatect): Multiple sclerosis, relapsing-remitting   ...

New at CADTH — July 2017

Published on: July 13, 2017
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Daclizumab beta (Zinbryta): Multiple sclerosis, relapsing CADTH pan-Canadian Oncology Drug Review (pCODR) Axitinib (Inlyta) Request for Advice: Metastatic renal cell carcinoma Obinutuzumab (Gazyva): Follicular lymphoma Cancer Drug Pipeline Information
Launched in 2015, the Cancer ...